Skip to main content
. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2

2.5. Analysis.

2.5

Comparison 2 Summary of findings table: etanercept (ET) 25 mg + disease‐modifying anti‐rheumatic drug (DMARD) vs. DMARD (partial responders to methotrexate (MTX)), Outcome 5 Withdrawals due to adverse events.